Skip to main content

What the FDA labels say about taking them together

Lenacapavir and lovastatin

Lenacapavir's FDA label of August 27, 2026 names lovastatin in its drug interactions section; the lovastatin label PlainMeds reads does not name lenacapavir. The lenacapavir label: “Initiate lovastatin and simvastatin with the lowest starting dose and titrate carefully while monitoring for safety (e.g., myopathy).”

Check it at the source: the lenacapavir FDA label on DailyMed (effective August 27, 2026, Gilead Sciences, Inc.); the lovastatin FDA label on DailyMed (effective May 6, 2026, Lupin Pharmaceuticals, Inc.).

What does the lenacapavir label say about lovastatin?

Lenacapavir label, drug interactions

Concomitant Drug Class/Drug Name: HMG-CoA Reductase Inhibitors: lovastatin simvastatin; Effect on Concentration ↑ = Increase, ↓ = Decrease.: ↑ lovastatin ↑ simvastatin; Clinical Comment: Initiate lovastatin and simvastatin with the lowest starting dose and titrate carefully while monitoring for safety (e.g., myopathy).

Source: FDA drug label (Sunlenca), Gilead Sciences, Inc., effective August 27, 2026 (SPL set e5652804-29c4-40d7-aeb2-0142ed2a7b5b), via openFDA; the full label on DailyMed

What does the lovastatin label say about lenacapavir?

Lovastatin's label (effective May 6, 2026) does not name lenacapavir in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Lovastatin), Lupin Pharmaceuticals, Inc., effective May 6, 2026 (SPL set df7ddf4f-d569-431e-81f1-9129d7043150), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Lenacapavir generic labelers
19Lovastatin generic labelers
LenacapavirLovastatin
Labeled forHIVHigh cholesterol, Heart attack and coronary artery disease
Boxed warningNoNo
Pharmacy cost (NADAC)n/a$0.0436 per tablet 20 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?